Your browser doesn't support javascript.
loading
Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment.
Zhang, Jie; Gao, Yuqi; Zhang, Zipeng; Zhao, Jinbo; Jia, Wenshuang; Xia, Chengcai; Wang, Fugang; Liu, Tingting.
Afiliación
  • Zhang J; Department of Medicinal Chemistry, School of Pharmacy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, China.
  • Gao Y; College of Radiology, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, China.
  • Zhang Z; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, Shandong 250117, China.
  • Zhao J; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, Shandong 250117, China.
  • Jia W; Department of Medicinal Chemistry, School of Pharmacy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, China.
  • Xia C; Department of Chemistry and Biology, Jilin Provincial Key Laboratory of Carbon Fiber Development and Application, Changchun University of Technology, Changchun, Jilin 130012, China.
  • Wang F; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, Shandong 250117, China.
  • Liu T; Department of Medicinal Chemistry, School of Pharmacy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, China.
J Med Chem ; 65(24): 16099-16127, 2022 12 22.
Article en En | MEDLINE | ID: mdl-36512711

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Poli(ADP-Ribosa) Polimerasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Poli(ADP-Ribosa) Polimerasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos